Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

TREATMENT.COM AI Aktie

 >TREATMENT.COM Aktienkurs 
0.226 EUR    -4.2%    (Tradegate)
Ask: 0.231 EUR / 0 Stück
Bid: 0.214 EUR / 0 Stück
Tagesumsatz: 25000 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>TREATMENT.COM Performance
1 Woche: -7,8%
1 Monat: -8,9%
3 Monate: -13,7%
6 Monate: -39,9%
1 Jahr: -51,3%
laufendes Jahr: -31,9%
>TREATMENT.COM AI Aktie
Name:  TREATMENT.COM AI O.N.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA8949421017 / A3EYD8
Symbol/ Ticker:  939 (Frankfurt)
Kürzel:  FRA:939, ETR:939, 939:GR
Index:  -
Webseite:  https://treatment.com/
Marktkapitalisierung:  18.48 Mio. EUR
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  1510 / 11.5 / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  TREATMENT.COM AI, TREATMENT.COM, TREATMENT COM
Letzte Datenerhebung:  06.07.25
>Eigentümer
Aktien: -
f.h. Aktien: -
Insider Eigner: -
Instit. Eigner: -
Leerverk. Aktien: -
>Peer Group

 
20.06.25 - 23:30
Treatment.com AI Grants Stock Option and RSUs (GlobeNewswire EN)
 
VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) announces that it has granted 799,920 restricted share units (“RSUs”) and 162,480 stock options (“Options”) to officers, directors, consultants and employees of the Company....
11.06.25 - 14:03
Repeat: Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients (GlobeNewswire EN)
 
Updated AI-powered OSCE platform launched to enhance medical education delivery and evaluation.Successfully deployed at University of Minnesota with 240 students and potential of ~40% cost savings.Features AI-simulated patients and real-time scoring to support faster, accurate and objective assessments.Preliminary results presented at 2025 AAMC annual GIR meeting in Minneapolis. VANCOUVER, BC, June 11, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce that it has released its latest version of the Medical Education Suite (MES). The University of Minnesota Medical School has successfully completed a live deployment of Treatment.com AI's new Medical Education Suite (MES), an AI-powered clinical skills assessment platform designed to support medical schools in delivering scalable, rigorous, and cost-effective Objective Structured Clinical Examinations (OSCEs).‏‏The deployment, conducted with over 240 third-year medical stu...
11.06.25 - 09:03
Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients (GlobeNewswire EN)
 
Updated AI-powered OSCE platform launched to enhance medical education delivery and evaluation.Successfully deployed at University of Minnesota with 240 students and potential of ~40% cost savings.Features AI-simulated patients and real-time scoring to support faster, accurate and objective assessments.Preliminary results presented at 2025 AAMC annual GIR meeting in Minneapolis. VANCOUVER, BC, June 11, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce that it has released its latest version of the Medical Education Suite (MES). The University of Minnesota Medical School has successfully completed a live deployment of Treatment.com AI's new Medical Education Suite (MES), an AI-powered clinical skills assessment platform designed to support medical schools in delivering scalable, rigorous, and cost-effective Objective Structured Clinical Examinations (OSCEs).‏‏The deployment, conducted with over 240 third-year medical stud...
05.06.25 - 11:48
Treatment.com AI on front line of the quest to enhance healthcare system efficiency (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
04.06.25 - 22:00
Treatment.com AI on front line of the quest to enhance healthcare system efficiency (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
04.06.25 - 14:03
Repeat: Rocket Doctor, a Treatment.com AI company, Joins Larta Institute′s 2025 Heal.LA Accelerator Cohort to Expand Access to Virtual Care (GlobeNewswire EN)
 
Selection aims to accelerate Rocket Doctor's mission to deliver accessible, tech-enabled care to underserved communities. Selection aims to accelerate Rocket Doctor's mission to deliver accessible, tech-enabled care to underserved communities....
04.06.25 - 09:03
Rocket Doctor, a Treatment.com AI company, Joins Larta Institute′s 2025 Heal.LA Accelerator Cohort to Expand Access to Virtual Care (GlobeNewswire EN)
 
Selection aims to accelerate Rocket Doctor's mission to deliver accessible, tech-enabled care to underserved communities. Selection aims to accelerate Rocket Doctor's mission to deliver accessible, tech-enabled care to underserved communities....
28.05.25 - 14:54
Treatment.com AI and Rocket Doctor Celebrate Recognition from UC Berkeley, Harvard, and AARP for Leadership in Health Innovation (GlobeNewswire EN)
 
From classrooms to conferences, Rocket Doctor earns national spotlight for transforming virtual care delivery From classrooms to conferences, Rocket Doctor earns national spotlight for transforming virtual care delivery...
27.05.25 - 23:36
Treatment.com AI Grants Stock Options and RSUs (GlobeNewswire EN)
 
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES...
15.05.25 - 15:09
Treatment.com AI and Rocket Doctor Applaud US Health Secretary RFK Jr.′s Call for Greater Investment in Telehealth and AI-Driven Diagnostic Tools (GlobeNewswire EN)
 
‏VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) and Rocket Doctor, its wholly owned online care platform, applaud United States Secretary of Health and Human Services, Robert F. Kennedy Jr., for his remarks during the House Appropriations Committee Budget Hearing yesterday, where he championed the potential role of telehealth and artificial intelligence in improving access to care.‏...
10.04.25 - 09:03
Treatment.com AI Closes Previously Announced Acquisition of Rocket Doctor Inc. (GlobeNewswire EN)
 
Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...
20.03.25 - 13:03
REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access (GlobeNewswire EN)
 
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care. Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care....
20.03.25 - 08:03
Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access (GlobeNewswire EN)
 
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care. Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care....
14.03.25 - 22:03
TREATMENT.COM AI INC. EXTENDS TERM OF MARKETING SERVICES PROVIDED BY I2I MARKETING GROUP (GlobeNewswire EN)
 
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES...
13.03.25 - 14:15
TREATMENT.COM AI INC. ANNOUNCES CLOSING OF UPSIZED BROKERED LIFE OFFERING OF UNITS (GlobeNewswire EN)
 
Vancouver, British Columbia, March 13, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that further to its news releases dated February 27, 2025 and March 3, 2025, it has closed its previously announced brokered private placement under the Listed Issuer Financing Exemption (the “Offering”) with Ventum Capital Corp., (the “Underwriter”) who acted as underwriter pursuant to an underwriting agreement dated March 13, 2025 (the “Underwriting Agreement”)....
28.02.25 - 14:03
Repeat: TREATMENT.COM AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) BOUGHT DEAL PRIVATE PLACEMENT (GlobeNewswire EN)
 
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States...
28.02.25 - 03:48
TREATMENT.COM AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) BOUGHT DEAL PRIVATE PLACEMENT (GlobeNewswire EN)
 
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States...
25.02.25 - 09:03
Rocket Doctor Approved as In-Network Provider for New York Medicaid, Expands Partnership with EngageWell to Enhance Care (GlobeNewswire EN)
 
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Approval as an In-Network Provider for New York Medicaid Strengthening Access to Virtual Healthcare Across the State and Collaboration with EngageWell....
20.02.25 - 10:18
Die CEOs von Treatment.com AI und Rocket Doctor diskutieren in einem Kamingespräch die kürzlich angekündigte Übernahme und die zukünftige Nutzung von KI im Gesundheitssektor (IRW Press)
 
Diese Pressemitteilung darf nicht über US-amerikanische Medienkanäle verbreitet werden. Vancouver, BC 20. Februar 2025 Treatment.com AI Inc. (Treatment AI oder das Unternehmen) (WKN: A3EYD8 CSE:......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!